MRP-L37 Inhibitors

Chemical inhibitors of Large ribosomal subunit protein mL37 (MRP-L37) target the protein by disrupting essential processes in mitochondrial protein synthesis, a key area of MRP-L37's functional role. Chloramphenicol, Tetracycline, Erythromycin, Azithromycin, Linezolid, and Clindamycin exert their inhibitory effects through interactions with the mitochondrial ribosome. Chloramphenicol inhibits MRP-L37 by hindering peptide bond formation in the ribosome, which is crucial for the protein's role in synthesizing mitochondrial proteins. Tetracycline and Erythromycin achieve inhibition by binding to the mitochondrial ribosome, thus disrupting aminoacyl-tRNA's access, a critical step in the protein synthesis process. Similarly, Azithromycin and Linezolid interfere with MRP-L37's function by obstructing the peptidyl transferase activity of the mitochondrial ribosome. Clindamycin targets the same pathway, affecting peptide bond formation and, consequently, the synthesis of proteins that involve MRP-L37. Other selected inhibitors, such as Doxycycline, Minocycline, Puromycin, Daptomycin, Fusidic Acid, and Rifampicin, utilize different mechanisms to inhibit MRP-L37. Doxycycline and Minocycline inhibit MRP-L37 by binding to the mitochondrial ribosome and preventing the incorporation of amino acids into growing peptide chains, directly impacting the protein's synthesis function. Puromycin disrupts the peptide elongation process, a key phase in protein synthesis where MRP-L37 is active. Daptomycin's mode of inhibition involves disrupting the mitochondrial membrane potential, which is essential for effective protein synthesis involving MRP-L37. Fusidic Acid targets the elongation factor G (EF-G) in the mitochondrial ribosome, affecting the translocation step in protein synthesis. Rifampicin inhibits MRP-L37 indirectly by binding to mitochondrial RNA polymerase, thus influencing the overall process of protein synthesis in which MRP-L37 is integral. Each of these chemicals targets specific processes in mitochondrial protein synthesis, thereby contributing to the inhibition of MRP-L37's functional role in this vital cellular activity.